|
|
|
| United States Patent | 4104314 |
| Link to this page | http://www.wikipatents.com/4104314.html |
| Inventor(s) | Terrell; Ross C. (Plainfield, NJ) |
| Abstract | This disclosure is directed to novel ethers of the formula:
CF.sub.3 CH.sub.a X.sub.b --O--CF.sub.2 CH.sub.c F.sub.d Cl.sub.e
wherein X is fluorine, chlorine or bromine, preferably fluorine, a is 1 or
2, b is 0 or 1, a plus b are 2, preferably both a and b being 1, c is 0 or
1, d is 0 to 2, e is 0 to 2, c plus d plus e are 3, preferably each of c,
d, and e is 1, and a plus c are 1 or 2, preferably 2, with the proviso
that when e is 1 or 2, X is fluorine or bromine, preferably fluorine. The
compounds having less than eight fluorine atoms per molecule are useful as
anesthetics, and all of the compounds are useful as solvents and
dispersants for fluorinated materials. A highly preferred compound useful
as an anesthetic is 1,2,2,2-tetrafluoroethyl
1',1',2'-trifluoro-2'-chloroethyl ether. |
|
|
|
Title Information  |
|
|
|
|
|
Drawing from US Patent 4104314 |
|
|
Ether compounds |
|
|
|
|
|
| Publication Date |
August 1, 1978 |
|
|
|
|
|
| Filing Date |
September 6, 1977 |
|
|
|
|
|
|
|
|
|
|
|
| Parent Case |
This is a division of application Ser. No. 705,369, filed July 14, 1976 now
U.S. Pat. No. 4,059,639; which was a divisional of Ser. No. 633,763, filed
Nov. 20, 1975, now U.S. Pat. No. 3,987,111 issued Oct. 19, 1976; which was
a divisional of Ser. No. 367,596, filed June 6, 1973, now U.S. Pat. No.
3,947,595 issued Mar. 30, 1976; which was a divisional of Ser. No. 170,954
filed Aug. 11, 1971, now U.S. Pat. No. 3,764,706 issued Oct. 9, 1973. |
|
|
|
|
|
|
|
|
|
|
|
|
|
Title Information  |
|
|
Description  |
|
|
This invention relates to the novel ethers of the formula:
CF.sub.3 CH.sub.a X.sub.b --O--CF.sub.2 CH.sub.c F.sub.d Cl.sub.e
wherein X is fluorine, chlorine or bromine, preferably fluorine, a is 1 or
2, b is 0 or 1, a plus b are 2, preferably both a and b being 1, c is 0 or
1, d is 0, 1 or 2, e is 0, 1 or 2, c plus d plus e are 3, preferably each
of c, d, and e is 1, and a plus c are 1 or 2, preferably 2, with the
proviso that when e is 1 or 2, X, if present, is fluorine or bromine,
preferably fluorine. Preferably when e is 1 or 2, b is 1. These ethers
which have less than 8 fluorine atoms per molecule, especially 6 or 7
fluorine atoms per molecule, can be used to produce anesthesia in
anesthetic-susceptible mammals. All of the ethers of this invention are
easily miscible with other organic liquids, including fats and oils, and
have useful solvent properties. These ethers are useful, for example, as
solvents for fluorinated olefins and other fluorinated materials such as
fluorowaxes. The ethers can also be used to prepare pastes and dispersions
of such fluorine-containing materials useful for coatings and the like,
and can be used as degreasing agents. In the latter capacity, for example,
the ether compounds of this invention can be used as solvents to remove
grease or other oily substances from metal surfaces that are to be
painted.
A highly preferred compound of the invention is 1,2,2,2-tetrafluoroethyl
1',1',2'-trifluoro-2'-chloroethyl ether having the formula CF.sub.3
CHF--O--CF.sub.2 CHFCl. This compound is normally a clear, colorless
liquid with an ethereal odor. This ether has the following physical
properties: b.p. 65.5.degree. C. at 760 mm.; vapor pressure 175 mm. at
25.degree. C.; specific gravity 1.52; and molecular weight 234.5. The
compound is nonflammable, soda lime stable, and a potent anesthetic for
inhalation anesthetic-susceptible mammals.
The compounds of the present invention can be prepared by the fluorination,
chlorination or bromination of the corresponding halogen-containing ethers
to substitute one or two additional halogen atoms per molecule in place of
hydrogen atoms of the feed. The ethers of the invention may also be formed
by the replacement of a halogen atom on the feed by another halogen atom,
e.g., the substitution of a fluorine atom for a bromine atom. Suitable
feedstocks for these reactions can be obtained in several ways and one
procedure involves the reaction of a prehalogenated ethylene with
2,2,2-trifluoroethanol. The perhalogenated ethylenes have the formula
CF.sub.2 .dbd.CX.sub.2 in which X is fluorine or chlorine. These reactions
can be conducted in the presence of potassium hydroxide and a small amount
of .alpha.-pinene. Suitable temperatures for the reactions are generally
in the range of about 30.degree. to 50.degree. C.
The chlorination or bromination of the ethers resulting from the foregoing
reaction can be conducted with the use of molecular chlorine or bromine.
Chlorine can be reacted conveniently at temperatures of about 50.degree.
to 60.degree. C. in the presence of light. In the reaction gaseous
chlorine can be passed into the liquid ether feed, and the chlorine can be
added to the reactor at the approximate rate it reacts. If desirable, the
reactor can be cooled to control the reaction temperature. Bromination of
the ethers can be effected by passing a mixture of gaseous bromine and an
inert gas such as nitrogen along with ether feed in the vapor phase
through a reaction zone maintained at elevated temperatures, e.g. about
400.degree. to 550.degree. C. In either of these reaction systems the
products can be separated by fractional distillation or gas chromatography
techniques.
The ethers of this invention can be made by a flourination process
involving the use of molecular fluorine. For example CF.sub.3 CH.sub.2
OCF.sub.2 CHFCl can then be converted to a mixture containing CF.sub.3
CHFOCF.sub.2 CHFCl, CF.sub.3 CH.sub.2 OCF.sub.2 CF.sub.2 Cl and CF.sub.3
CHFOCF.sub.2 CF.sub.2 Cl, all compounds of the present inventions, by
reaction with gaseous fluorine to replace one of the hydrogen atoms on the
1-carbon atom which bears two hydrogen atoms and/or replace the hydrogen
atom on the 2-carbon atom bearing a chlorine atom. The fluorination can be
accomplished by mixing the feed compound with carbon tetrachloride or
other fluorine and/or chlorine-containing alkane solvents which are
preferably perhalogenated, and then contacting the mixture with gaseous
fluorine at reduced temperatures, e.g. below about 0.degree. C.,
preferably about -20.degree. to 0.degree. C. Lower alkyl ethers which are
perhalogenated with one or both of chlorine or fluorine may also be
suitable solvents. Hydrogen fluorine is evolved from the reaction mixture
during this fluorination procedure and the Hf can be collected by passage
of the evolved gases through a water scrubber. After a substantial amount
of the feed ether has reacted, the desired products can be separated from
the reaction mixture by gas chromatography. This fluorination procedure
can be used to prepare various compounds of the invention from the
corresponding ethers.
The following examples will serve further to illustrate the present
invention.
EXAMPLE I
Preparation of the Intermediate CF.sub.3 CH.sub.2 OCF.sub.2 CHF.sub.2
Tetrafluoroethylene (400 g.) was added as a gas at 300-500 psi to a stirred
one liter autoclave containing a solution of potassium hydroxide (50 g.)
in CF.sub.3 CH.sub.2 O (400 cc.) and also a small amount of .alpha.-pinene
(10 g.). The autoclave was heated to 40.degree. C. to initiate the
reaction. The reaction then proceeded smoothly with a slight exotherm and
was maintained at 35.degree.-45.degree. C. The crude product was washed
with water and then fractionally distilled to obtain 350 g. of CF.sub.3
CH.sub.2 OCF.sub.2 CHF.sub.2, b.p. 55.5.degree. C. at 760 mm.
EXAMPLE II
Preparation of CF.sub.3 CHClOCF.sub.2 CF.sub.2 H
CF.sub.3 CH.sub.2 OCF.sub.2 CF.sub.2 H (140 g.) was reacted with chlorine
gas at a temperature of 50.degree.-60.degree. C. in a glass apparatus in
the presence of incandescent light. When 0.7 mole of chlorine per mole of
ether had reacted, the crude product weighed 157 g. and contained 60% of
CF.sub.3 CHClOCF.sub.2 CF.sub.2 H as shown by gas chromatography. This
product was separated and purified by fractional distillation and
preparative vapor phase chromatography. The product analyzed as follows:
Calculated for C.sub.4 H.sub.2 ClF.sub.7 O: C, 20.5; H, 0185, b.p.
66.degree. C. Found: C, 20.8; H, 1.03.
Specific gravity -- 1.5
Vapor pressure -- 175 mm. Hg./25.degree. C.
Odor -- slight
Flammability -- non-flammable.
The structure CF.sub.3 CHClOCF.sub.2 CF.sub.2 H was confirmed by the n.m.r.
and infrared spectra.
EXAMPLE III
Preparation of CF.sub.3 CHBrOCF.sub.2 CF.sub.2 H
CF.sub.3 CH.sub.2 OCF.sub.2 CF.sub.2 H (110 g.) was reacted with bromine
(125 g.) by passing a mixture of the two diluted with a stream of nitrogen
through a 12 inch .times. 1 inch glass tube heated to 475.degree. C. The
effluent product was condensed in a "Dry Ice" trap and purified by
fractional distillation and preparative gas chromatography to give
CF.sub.3 CHBrOCF.sub.2 CF.sub.2 H., b.p. 80.degree. C., n.sub.D.sup.25
1.3155. This product analyzed as follows:
Calculated for C.sub.4 H.sub.2 F.sub.7 BrO: C, 17.4; H, 0.74. Found: C,
17.52; H, 0.73.
Specific gravity -- 1.8
Vapor pressure -- 100 mm. Hg./25.degree. C.
Odor -- not unpleasant
Flammability -- non-flammable
EXAMPLE IV
Preparation of CF.sub.3 CHFOCF.sub.2 CF.sub.2 H
CF.sub.3 CH.sub.2 OCF.sub.2 CF.sub.2 H (100 g.) was fluorinated at
-20.degree. C. in CCl.sub.4 (350 cc.) in a glass reactor using fluorine
diluted with argon (F.sub.2 at 80 cc./min. argon at 160 cc./min.). After
seven hours, conversion of the feed ether to CF.sub.3 CHFOCF.sub.2
CHF.sub.2 was 28 mole %. The product CF.sub.3 CHFOCF.sub.2 CHF.sub.2 was
isolated by distillation and preparative gas chromatography, b.p.
41.degree. C., and analyzed as follows:
Calculated for C.sub.4 H.sub.2 F.sub.8 O: C, 22.0; H, 0.92. Found: C, 22.1;
H, 0.9.
Specific gravity -- 1.4
Vapor pressure -- 430 mm. Hg./25.degree. C.
Odor -- None
Flammability -- non-flammable
The assigned structure was confirmed by the n.m.r. spectrum.
EXAMPLE V
Preparation of CF.sub.3 CHFOCF.sub.2 CHCl.sub.2 and CF.sub.3 CHFOCF.sub.2
CFCl.sub.2
CF.sub.3 CH.sub.2 OCF.sub.2 CHCl.sub.2 (232 g.) (proposed as in Example I
but using CF.sub.2 .dbd.CCl.sub.2 instead of CF.sub.2 .dbd.CF.sub.2) was
fluorinated in Freon 113 (CCl.sub.3 CF.sub.3) (850 cc.) at -20.degree. C.
in a glass reactor using fluorine diluted with argon, (F.sub.2 at 80
cc./min., argon at 160 cc./min.). After seven hours, 42% of the starting
ether was converted to a mixture of CF.sub.3 CHFOCF.sub.2 CHCl.sub.2 and
CF.sub.3 CH.sub.2 OCF.sub.2 -- CFCl.sub.2. CF.sub.3 CHFOCF.sub.2
CHCl.sub.2, b.p. 89.degree. C., n.sub.D.sup.20 1.3261, was isolated by gas
chromatography and analyzed as follows:
Calculated for C.sub.4 H.sub.2 Cl.sub.2 F.sub.6 O: C, 19.19; H, 0.8. Found:
C, 19.2; H, 0.88.
Specific gravity -- 1.54
Vapor pressure -- 58 mm. Hg./25.degree. C.
Odor -- etheral
Flammability -- Non-flammable.
The resulting mixture of fluorinated ethers can be further fluorinated
using the same conditions to give additional quantities of CF.sub.3
CHFOCF.sub.2 CFCl.sub.2, b.p. 75.degree. C., which can be separated by gas
chromatography. This product analyzed as follows:
Calculated for C.sub.4 HCl.sub.2 F.sub.7 O: C, 17.85; H, 0.37. Found: C,
18.10; H, 0.40.
Specific gravity -- 1.67
Vapor pressure -- 120 mm. Hg./25.degree. C.
Flammability -- non-flammable.
EXAMPLE VI
2,2,2-Trifluoroethyl 1',1',2'-trifluoro-2'-chloroethyl ether (CF.sub.3
CH.sub.2 OCF.sub.2 CHFCl) (216.5 g., 1.0 m.) (prepared as in Example I but
using CF.sub.2 .dbd.CFCl instead of CF.sub.2 .dbd.CF.sub.2) in 900 ml. of
carbon tetrachloride was fluorinated at -15.degree. C. in a glass flask
using 33% fluorine in argon (F.sub.2 at 80 cc./min., argon at 160
cc./min.) at a rate of 0.2 mole fluorine per hour. After 7 hours, 36% of
the starting ether had been converted to fluorinated products, and the
reaction mixture analyzed as follows:
0.9% CF.sub.3 CHF--O--CF.sub.2 CF.sub.2 Cl
2.35% CF.sub.3 CH.sub.2 --O--CF.sub.2 CF.sub.2 Cl
2.59% CF.sub.3 CHF--O--CF.sub.2 CHFCl
5.56% CF.sub.3 CH.sub.2 --O--CF.sub.2 CHFCl
88.53% CCl.sub.4
The products CF.sub.3 CHF--O--CF.sub.2 CHFCl, CF.sub.3 CH.sub.2 OCF.sub.2
CF.sub.2 Cl, and CF.sub.3 CHFOCF.sub.2 CF.sub.2 Cl were separated from
unreacted starting ether and were recovered by fractional distillation.
These ether products were further purified by preparative gas
chromatography. The preparative gas chromatography products separated were
as follows:
Cf.sub.3 chfocf.sub.2 chfcl, b.p. 65.5.degree. C.
Calculated for C.sub.4 H.sub.2 ClF.sub.7 O: F, 56.6%. Found: F, 56.6%.
Specific gravity -- 1.52
Vapor pressure -- 175 mm. Hg./25.degree. C.
Odor -- ethereal
Flammability -- non-flammable
Cf.sub.3 ch.sub.2 ocf.sub.2 cf.sub.2 cl, b.p. 57.degree. C.
Calculated for C.sub.4 H.sub.2 ClF.sub.7 O: F, 56.6%. Found: F, 56.7%.
Specific gravity -- 1.48
Vapor pressure -- 240 mm. Hg./25.degree. C.
Odor -- ethereal
Flammability -- non-flammable
Cf.sub.3 chfocf.sub.2 cf.sub.2 cl, b.p. 42.5.degree. C.
Calculated for C.sub.4 HClF.sub.8 O: F, 60.1%. Found: F, 60.1%.
Specific gravity -- 1.52
Vapor pressure -- 410 mm. Hg./25.degree. C.
Flammability -- non-flammable.
The identity of each of these ether products was confirmed by the nuclear
magnetic resonance (n.m.r.) spectrum.
EXAMPLE VII
Preparation of CF.sub.3 CHBrOCF.sub.2 CHFCl
CF.sub.3 CH.sub.2 OCF.sub.2 CHFCl (104 g.) and bromine (85 g.) were
vaporized in a stream of nitrogen at 15-20 l/hr. The gaseous mixture was
then passed through a 1 inch .times. 12 inch glass tube at 475.degree. C.
The crude product (137 g.) was condensed in a "Dry Ice" trap and purified
by fractional distillation and preparative gas chromatography. The product
CF.sub.3 CHBrOCF.sub.2 CHFCl had b.p. 109.degree. C., n.sub.D.sup.20
1.3525 and analyzed as follows:
Calculated for C.sub.4 H.sub.2 BrClF.sub.6 O: C, 16.25; H, 0.68. Found: C,
16.34; H, 0.57.
Specific gravity -- 1.9
Vapor pressure -- 30 mm. Hg./25.degree. C.
Odor -- not unpleasant
Flammability -- non-flammable
The structure of the product ether was confirmed by the n.m.r. and infrared
spectra.
In order to determine the potency of the ethers of the present invention as
inhalation anesthetics in combination with oxygen, tests were carried out
on mice. The compounds tested were at least 99.5% pure as determined by
vapor phase chromatography. In the tests, the ether compound is
administered to test mice by a standard procedure in which a measured
quantity of the agent is placed in a laboratory jar and allowed to
completely vaporize so as to give a calculated vapor concentration. The
test mice are then quickly placed in the jar and observed. Anesthesia is
determined by observing the righting reflex of the mice. Recovery time is
measured beginning when the mice are transferred from the test jar to room
air and ending when the mice are observed to be able to walk.
In such tests the 1,2,2,2-tetrafluoroethyl
1',1',2'-trifluoro-2'-chloroethyl ether induced a light level of
anesthesia in 53 seconds when used at a vapor concentration of 2%. The
induction was accompanied by brief excitement. Recovery required 75
seconds. At 2.5% concentration the induction period lasted 40 seconds and
recovery required 52 seconds. There was brief excitement during induction
and recovery. Respiration slowed to 64 per minute during maintenance of
the anesthesia, but the color of the mice remained good.
Thus it is seen that the compound 1,2,2,2-tetrafluoroethyl
1',1',2'-trifluoro-2'-chloroethyl ether exhibited good anesthetic
properties in inhalation anesthetic-susceptible mammals, giving rapid
induction and recovery and moderate respiratory depression. The compound
is soda lime stable, and lends iself well to effective use as an inhalant
anesthetic in respirable mixtures containing life-supporting
concentrations of oxygen.
Using a 2.5% vapor concentration of 2-chloroperfluoroethyl
2',2',2'-trifluoroethyl ether a low level of anesthesia was induced with
hyperexcitability in 7 minutes. One of five mice died of respiratory
failure during maintenance of the anesthesia. The animals were excitable
in recovery and one became cyanotic, but survived.
Using a 1.25% vapor concentration of 2-hydroperfluoroethyl
1'-chloro-2'-2'-2'-trifluoroethyl ether, very light anesthesia was induced
in the mice in 4.7 minutes. Respiration was slowed and animals rose to
their feet when stimulated. At 2.5% concentration there was deep
anesthesia in 1.3 minutes; recovery required 1.9 minutes. Respirations
were abdominal during maintenance of the anesthesia, and the animals were
hyperflexic and twitching during recovery. At 5% concentration the
induction required 0.5 minute and the recovery took 3.9 minutes. The
anesthesia was very deep at this concentration, one mouse in five arching
its back during maintenance, and two in five arching theirs during
recovery. There was jumping and twitching, and respiration was very
depressed. Recovery was accompanied by marked tremors.
The compound 1-bromo-1-hydroperfluoroethyl 2'-hydroperfluoroethyl ether
when used at 1.0% vapor concentration induced anesthesia in 1 minute 14
seconds; recovery therefrom required 3 minutes 12 seconds. Maintenance at
this concentration was marked by motor activity at the start, leading to
flaccidity and much respiratory depression. At 1.5% vapor concentration
anesthesia was induced in 1 minute 8 seconds and recovery required 4
minutes 2 seconds. Induction was accompanied by much excitement.
Maintenance proceeded as with 1% concentration, with the respiration rate
being depressed to 20 per minute. At 2.5% vapor concentration there was
marked excitement on induction, which required 43 seconds, and the
respiration rate fell to 16 per minute. Recovery took 6 minutes 37
seconds.
Using 1-bromo-2,2,2-trifluoroethyl 2'-chloro-1',1',2'-trifluoroethyl ether
at 0.25% vapor concentration required 2 minutes 32 seconds to induce a
light anesthesia with moderate respiratory depression during maintenance.
Recovery took 6 minutes 13 seconds. At 0.5% concentration the induction
occurred in 2 minutes 35 seconds and the recovery in 4 minutes 58 seconds.
The excitement phase during induction was long, and moderate respiratory
depression was observed during maintenance. At 0.75% concentration the
inducement required 1 minute 16 seconds; again it was with excitement. The
respiration rate fell to 40-60 per minute during maintenance. Recovery
took 9 minutes. A level of 2.5% vapor concentration was lethal to all of
the test mice.
Using 0.5% vapor concentration of 2,2-dichloro-1,1-difluoroethyl
1',1',2',2'-tetrafluoroethyl ether, induction of a very light anesthesia
required 1 minute 29 seconds and recovery therefrom took 52 seconds. The
induction was accompanied by mild excitement. At a level of 1.0% a light
anesthesia was induced, again with mild excitement, in 35 seconds.
Respiration was jerky and gasping during maintenance. Recovery required 3
minutes 24 seconds. Smooth induction occurred in 10 seconds when using
2.5% vapor concentration. There was some respiratory depression during
maintenance and mild cyanosis in recovery. The recovery took 9 minutes and
the mice were sluggish afterwards.
At a vapor concentration of 5%, the compound 1,2,2,2-tetrafluoroethyl
1',1',2'-trifluoro-2',2'-dichloroethyl ether induced anesthesia in the
test mice in 1 minute 30 seconds. The animals were restless in
maintenance, with gasping, jumping, urination, and some cyanosis. The
recovery was with excitement and required 35 seconds.
The compounds 2-chloro-1,1,2,2-tetrafluoroethyl
1',2',2',2'-tetrafluoroethyl ether and 1,2'-dihydroperfluorodiethyl ether
were both tested at 2.5% and 5.0% vapor concentrations and were observed
to have a sedative effect on the mice; but they did not induce anesthesia.
Examples of other halogenated diethyl ethers which I have considered as
possible anesthetics are listed below, but none was satisfactory.
______________________________________
Compound Properties
______________________________________
CF.sub.3 CH.sub.2 --O--CF.sub.2 CHFCl
Convulsant
CF.sub.3 CH.sub.2 --O--CF.sub.2 CF.sub.2 H
Convulsant
CF.sub.3 CHCl--O--CF.sub.2 CHFCl
Convulsant
CF.sub.3 CH.sub.2 --O--CH.sub.2 CF.sub.3
Convulsant
CF.sub.3 CH.sub.2 --O--CF.sub.2 CH.sub.2 F
Convulsant
CF.sub.3 CH.sub.2 --O--CF.sub.2 CHFBr
Anesthetic, convulsant
properties.
______________________________________
The effective amount of the compounds of this invention to be employed
depends on the level of anesthesia to which the mammal is to be brought,
the rate at which anesthesia is to be induced, and the length of time over
which anesthesia is to be maintained. Minor volume percentages, for
example about 0.25 to 5%, or somewhat more, of the compounds in respirable
mixtures containing life-supporting amounts of oxygen can be employed. The
amount used should be sufficient to provide a significant anesthetic
effect, but not so much as to produce unacceptable deleterious side
effects. The person controlling the anesthesia can easily regulate the
amount of the ether to be used, starting with a small amount, e.g. about
0.25%, and gradually increasing the amount until the desired plane of
anesthesia is reached. By then monitoring the physical properties of the
mammal, as is the usual procedure, the duration and plane of anesthesia
can be readily controlled.
It should be understood that the foregoing disclosure relates to preferred
embodiments of the invention and that it is intended to cover all changes
and modifications of the examples of the invention herein chosen for the
purpose of the disclosure which does not constitute departure from the
spirit and scope of the invention.
* * * * *
|
|
|
|
|
Description  |
|